A Synthetic Binder of Breast Cancer Stem Cells

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Cancer stem cells (CSCs) are implicated in drug resistance, metastasis, and cancer recurrence.
• Targeting CSCs is crucial for developing effective cancer treatments.
• A specific binder for CSCs is needed for research and therapeutic development.

Purpose of the Study:

• To identify a synthetic ligand that specifically binds to cancer stem cells (CSCs) in breast cancer.
• To evaluate the utility of the identified ligand for CSC isolation and characterization.

Main Methods:

• Cell-binding screening of a chemical library against breast cancer cell lines (MCF-7 and MDA-MB-231).
• Characterization of ligand binding to specific CSC populations (CD24-/CD44+/ALDH+).
• Affinity isolation of CSCs using ligand-immobilized beads.
• Analysis of stemness-associated gene expression and in vivo tumor growth studies.

Main Results:

• A synthetic ligand (1) was identified that specifically binds to CD24-/CD44+/ALDH+ CSCs.
• Ligand 1-immobilized beads enabled efficient affinity isolation of CSCs.
• Isolated CSCs exhibited increased stemness-associated transcription factor expression.
• In vivo studies showed accelerated tumor growth and increased migratory activity in the 1-binding CSC population.

Conclusions:

• The synthetic ligand 1 is a specific binder for breast cancer stem cells.
• Ligand 1 serves as a valuable tool for CSC isolation and research.
• This finding provides a foundation for developing CSC-targeting imaging and therapeutic agents.